# New colorectal cancer trials, last 30 days: 50 (2026)

Updated November 19, 2026.

50 new trials for colorectal cancer were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New colorectal cancer clinical trials, last 30 days: 50 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 6 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/new/colorectal-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 50
- Recruiting or not yet: 44
- Read on: November 19, 2026

## Trials

The 25 newest of 50, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947134 | A Study of GSK5864399 Administered Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumours | GlaxoSmithKline | Phase 1/2 | Not yet recruiting | Solid Tumours | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947134) |
| November 18, 2026 | NCT07946965 | A Prospective External Control Arm Study in Colorectal Cancer | N-Power Medicine | Observational | Not yet recruiting | Colorectal Cancer | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946965) |
| November 17, 2026 | NCT07942506 | The Effect of Health Education Conducted Using Two Different Methods on Individuals in a High-risk Age Group Regarding Their Health Beliefs... | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | Not applicable | Completed | Colorectal Cancer Screening | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942506) |
| November 17, 2026 | NCT07941843 | Lactoferrin Supplementation for FOLFOX-Related Toxicities in Colorectal Cancer | Damanhour University | Phase 2 | Not yet recruiting | Colorectal Cancer, Chemotherapy-Induced Peripheral Neuropathy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941843) |
| November 17, 2026 | NCT07941362 | 177Lu-ACT319 in FAP Expressing Solid Tumors | Actithera INC. | Phase 1/2 | Not yet recruiting | FAP-expressing Solid Tumors, Pancreatic Ductal Adenocarcinoma (PDAC), Biliary Tract Carcinoma (BTC) | 182 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941362) |
| November 17, 2026 | NCT07941310 | A Phase 2 Study of Bevacizumab Plus Erlotinib in EGFR-Amplified Metastatic Colorectal Cancer | Korea University Anam Hospital | Phase 2 | Not yet recruiting | Metastatic Colorectal Cancer, EGFR Amplified Colorectal Cancer | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941310) |
| November 16, 2026 | NCT07939815 | A Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies | Bristol-Myers Squibb | Phase 1/2 | Not yet recruiting | Advanced Solid Malignancies | 171 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939815) |
| November 16, 2026 | NCT07938021 | HLX22 Plus Serplulimab and Trastuzumab or Pertuzumab in HER2-Low Advanced Gastrointestinal Cancers | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 | Not yet recruiting | Gastric Cancer (Diagnosis), Colorectal Cancer (Diagnosis), Gastroesophageal Junction Cancer, Biliary Tract Cancer (BTC) | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938021) |
| November 16, 2026 | NCT07937696 | A Vaccine (Nous-209) for the Reduction of Colorectal Lesion Size in Patients With Lynch Syndrome | National Cancer Institute (NCI) | Phase 2 | Not yet recruiting | Colorectal Carcinoma, EPCAM Lynch Syndrome, Lynch Syndrome, MLH1 Lynch Syndrome, MSH2 Lynch Syndrome, MSH6 Lynch... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937696) |
| November 13, 2026 | NCT07936682 | PreCharge: An Innovative Digital Program to Increase Coping, Resilience, and Health Care Engagement Among Cancer Previvors | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Well-being, Hereditary Cancer Syndromes, Genetic Predisposition to Cancer | 574 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936682) |
| November 12, 2026 | NCT07932951 | Retrospective Analysis of a Psoralea Corylifolia (Buguzhi)-Containing TCM Formula for Gastrointestinal Cancers | Peking University Cancer Hospital & Institute | Observational | Active not recruiting | Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer (GC), Hepatocellular Carcinoma (HCC), Colorectal Cancer | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932951) |
| November 12, 2026 | NCT07931716 | Postoperative Energy and Protein Intake Attainment After Elective Laparoscopic Colorectal Cancer Surgery | First Affiliated Hospital of Chongqing Medical University | Observational | Not yet recruiting | Postoperative Gastrointestinal Dysfunction, Feeding Intolerance, Colorectal Cancer | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931716) |
| November 12, 2026 | NCT07931300 | Multicenter Study of SIS Patch in High-risk Colorectal Anastomosis | Beijing Chao Yang Hospital | Not applicable | Recruiting | Colorectal Cancer | 255 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931300) |
| November 10, 2026 | NCT07927270 | Symptomatic FIT for Colon Cancer Detection, a Pilot Study | University of California, San Diego | Observational | Not yet recruiting | Colorectal Cancer, Diagnosis, Advanced Colorectal Neoplasia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927270) |
| November 9, 2026 | NCT07927075 | Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression | Sir Run Run Shaw Hospital | Phase 2/3 | Enrolling by invitation | Colorectal Cancer | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927075) |
| November 9, 2026 | NCT07927049 | Evaluating the Efficacy of Chidamide in the Treatment of Initial Unresectable Metastatic Colorectal Cancer With High Expression of SULF1 | Sir Run Run Shaw Hospital | Phase 2/3 | Enrolling by invitation | Colorectal Cancer | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927049) |
| November 9, 2026 | NCT07926477 | Trastuzumab Rezetecan + Bevacizumab vs. TAS-102 + Bevacizumab in Pretreated mCRC With HER2 Low/Moderate Expression or HER2 Positivity With... | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 2 | Not yet recruiting | Colorectal Cancer | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926477) |
| November 9, 2026 | NCT07924189 | Association of Psychological Distress With Clinical Outcomes in Patients With Digestive System Cancers | Xuanwu Hospital, Beijing | Observational | Active not recruiting | Psychological Distress, Pancreatic Cancer, Colorectal Cancer, Gastric Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924189) |
| November 6, 2026 | NCT07923682 | Outcomes of Knife-Assisted Full-Thickness Resection for Rectal Lesions: A Multicenter Study | University Hospital, Ghent | Observational | Recruiting | Colorectal Cancer | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923682) |
| November 6, 2026 | NCT07922850 | Tailored Nutrition vs. Exercise Prehabilitation Before Colorectal Cancer Surgery | University Hospital of North Norway | Not applicable | Not yet recruiting | Colorectal Cancer, Colorectal Neoplasms | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922850) |
| November 6, 2026 | NCT07922642 | Nurse-Led Prehabilitation Before Major Abdominal Cancer Surgery | Alexandria University | Not applicable | Not yet recruiting | Colorectal Cancer | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922642) |
| November 5, 2026 | NCT07919951 | RAPID for Unresectable Colorectal Liver Metastases | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not applicable | Not yet recruiting | Colorectal Liver Metastases (CRCLM), Colorectal Neoplasms | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919951) |
| November 5, 2026 | NCT07919418 | A Patient-Derived 3D Bioprinted Colorectal Cancer-Stroma-Immune Triad Model Uncovers Microenvironmental Mechanisms of Chemoresistance and... | Peking Union Medical College Hospital | Observational | Recruiting | Colorectal Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919418) |
| November 4, 2026 | NCT07917429 | Real-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC | Fujian Medical University Union Hospital | Observational | Not yet recruiting | Colorectal Cancer Metastatic | 610 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917429) |
| November 3, 2026 | NCT07913906 | Alberta Cancer Exercise Dose in Colorectal Cancer | University of Calgary | Phase 2 | Not yet recruiting | Cancer, Colorectal Cancer | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913906) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 3 |
| Phase 1/2 | 5 |
| Phase 2 | 9 |
| Phase 2/3 | 3 |
| Phase 3 | 2 |
| Not applicable | 12 |
| Observational | 16 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| Sir Run Run Shaw Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| N-Power Medicine | 1 |
| Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | 1 |
| Damanhour University | 1 |
| Actithera INC. | 1 |
| Korea University Anam Hospital | 1 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| National Cancer Institute (NCI) | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| First Affiliated Hospital of Chongqing Medical University | 1 |
| Beijing Chao Yang Hospital | 1 |
| University of California, San Diego | 1 |
| Xuanwu Hospital, Beijing | 1 |
| University Hospital, Ghent | 1 |
| University Hospital of North Norway | 1 |
| Alexandria University | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| Peking Union Medical College Hospital | 1 |
| Fujian Medical University Union Hospital | 1 |
| University of Calgary | 1 |
| Vorarlberg Institute for Vascular Investigation and Treatment | 1 |
| Genfleet Therapeutics (Shanghai) Inc. | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B audio visual production companies in the United States](https://specstream.ai/data/businesses/b2b-audio-visual-production-companies/united-states)
- [Diners in the United States](https://specstream.ai/data/businesses/diners/united-states)
- [Indonesian restaurants in the United States](https://specstream.ai/data/businesses/indonesian-restaurants/united-states)
- [Pizza restaurants in the United States](https://specstream.ai/data/businesses/pizza-restaurants/united-states)
- [Truck rental companies in the United States](https://specstream.ai/data/businesses/truck-rental-companies/united-states)
- [Bottled water companies in the United States](https://specstream.ai/data/businesses/bottled-water-companies/united-states)
